Human Molecular Genetics, 2000, Vol. 9, No. 9 1369-1375
© 2000 Oxford University Press
Rett syndrome: analysis of MECP2 and clinical characterization of 31 patients
Abteilung Kinderheilkunde, Schwerpunkt Neuropädiatrie and 1Institut für Humangenetik, Georg-August-Universität Göttingen, Robert Koch Straße 40, D-37075, Göttingen, Germany
Only recently have mutations in MECP2 been found to be a cause of Rett Syndrome (RTT), a neurodevelopmental disorder characterized by mental retardation, loss of expressive speech, deceleration of head growth and loss of acquired skills that almost exclusively affects females. We analysed the MECP2 gene in 31 patients diagnosed with RTT. Sequencing of the coding region and the splice sites revealed mutations in 24 females (77.40%). However, no abnormalities were detected in any of the parents that were available for investigation. Eleven mutations have not been described previously. Confirming two earlier studies, we found that most mutations are truncating and only a few of them are missense mutations. Several females carrying the same mutation display different phenotypes indicating that factors other than the type or position of mutations influence the severity of RTT. Four females with RTT variants were included in the study. Three of these presented with preserved speech while the fourth patient with congenital RTT lacked the initial period of normal development. Detection of mutations in these cases reveals that they are indeed variants of RTT. They represent the mild and the severe extremes of RTT. Conclusions: mutations in MECP2 seem to be the main cause for RTT and can be expected to be found in ~77% of patients that fulfil the criteria for RTT. Therefore analysis of MECP2 should be performed if RTT is suspected. Three mutation hotspots (T158M, R168X and R255X) were confirmed and a further one (R270X) newly identified. We recommend screening for these mutations before analysing the coding region.
+ To whom correspondence should be addressed. Tel: +49 551 396210; Fax: + 49 551 396252; Email: phuppke@med.uni-goettingen.de
§ These authors contributed equally to this work
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  J. L. Neul, P. Fang, J. Barrish, J. Lane, E. B. Caeg, E. O. Smith, H. Zoghbi, A. Percy, and D. G. Glaze Specific mutations in Methyl-CpG-Binding Protein 2 confer different severity in Rett syndrome Neurology, April 15, 2008; 70(16): 1313 - 1321. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J.C. Carter, D.C. Lanham, D. Pham, G. Bibat, S. Naidu, and W.E. Kaufmann Selective Cerebral Volume Reduction in Rett Syndrome: A Multiple-Approach MR Imaging Study AJNR Am. J. Neuroradiol., March 1, 2008; 29(3): 436 - 441. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H. Archer, J. Evans, H. Leonard, L. Colvin, D. Ravine, J. Christodoulou, S. Williamson, T. Charman, M. E S Bailey, J. Sampson, et al. Correlation between clinical severity in patients with Rett syndrome with a p.R168X or p.T158M MECP2 mutation, and the direction and degree of skewing of X-chromosome inactivation J. Med. Genet., February 1, 2007; 44(2): 148 - 152. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P Huppke, E M Maier, A Warnke, C Brendel, F Laccone, and J Gartner Very mild cases of Rett syndrome with skewed X inactivation J. Med. Genet., October 1, 2006; 43(10): 814 - 816. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. L. Laurvick, M. E. Msall, S. Silburn, C. Bower, N. d. Klerk, and H. Leonard Physical and Mental Health of Mothers Caring for a Child With Rett Syndrome Pediatrics, October 1, 2006; 118(4): e1152 - e1164. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. Ventura, R. Galluzzi, S. M. Bacca, R. Giorda, and A. Massagli A novel familial MECP2 mutation in a young boy: clinical and molecular findings. Neurology, September 12, 2006; 67(5): 867 - 868. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H L Archer, S D Whatley, J C Evans, D Ravine, P Huppke, A Kerr, D Bunyan, B Kerr, E Sweeney, S J Davies, et al. Gross rearrangements of the MECP2 gene are found in both classical and atypical Rett syndrome patients J. Med. Genet., May 1, 2006; 43(5): 451 - 456. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. L. Ham, A. Kumar, R. Deeter, and N. C. Schanen Does Genotype Predict Phenotype in Rett Syndrome? J Child Neurol, September 1, 2005; 20(9): 768 - 778. [Abstract] [PDF]
|
|
|
|
|
|
A. L. Ham, A. Kumar, R. Deeter, and N. C. Schanen Does Genotype Predict Phenotype in Rett Syndrome? J Child Neurol, August 1, 2005; 20(8): 768 - 778. [Abstract] [PDF]
|
|
|
|
|
|
Jong Hee Chae, Hee Hwang, Yong Seung Hwang, Hee Jung Cheong, and Ki Joong Kim Influence of MECP2 Gene Mutation and X-Chromosome Inactivation on the Rett Syndrome Phenotype J Child Neurol, July 1, 2004; 19(7): 503 - 508. [Abstract] [PDF]
|
|
|
|
|
|
F Kammoun, N de Roux, O Boespflug-Tanguy, L Vallee, R Seng, M Tardieu, and P Landrieu Screening of MECP2 coding sequence in patients with phenotypes of decreasing likelihood for Rett syndrome: a cohort of 171 cases J. Med. Genet., June 1, 2004; 41(6): e85 - e85. [Full Text] [PDF]
|
|
|
|
 |
|
 V. Matarazzo and G. V. Ronnett Temporal and regional differences in the olfactory proteome as a consequence of MeCP2 deficiency PNAS, May 18, 2004; 101(20): 7763 - 7768. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. L. Neul and H. Y. Zoghbi Rett Syndrome: A Prototypical Neurodevelopmental Disorder Neuroscientist, April 1, 2004; 10(2): 118 - 128. [Abstract] [PDF]
|
|
|
|
 |
|
 R. C. Samaco, R. P. Nagarajan, D. Braunschweig, and J. M. LaSalle Multiple pathways regulate MeCP2 expression in normal brain development and exhibit defects in autism-spectrum disorders Hum. Mol. Genet., March 15, 2004; 13(6): 629 - 639. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L Colvin, H Leonard, N de Klerk, M Davis, L Weaving, S Williamson, and J Christodoulou Refining the phenotype of common mutations in Rett syndrome J. Med. Genet., January 1, 2004; 41(1): 25 - 30. [Full Text] [PDF]
|
|
|
|
|
|
J. Christodoulou and L. S. Weaving MECP2 and Beyond: Phenotype--Genotype Correlations in Rett Syndrome J Child Neurol, October 1, 2003; 18(10): 669 - 674. [Abstract] [PDF]
|
|
|
|
|
|
S Kudo, Y Nomura, M Segawa, N Fujita, M Nakao, C Schanen, and M Tamura Heterogeneity in residual function of MeCP2 carrying missense mutations in the methyl CpG binding domain J. Med. Genet., July 1, 2003; 40(7): 487 - 493. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H Gill, J P Cheadle, J Maynard, N Fleming, S Whatley, T Cranston, E M Thompson, H Leonard, M Davis, J Christodoulou, et al. Mutation analysis in the MECP2 gene and genetic counselling for Rett syndrome J. Med. Genet., May 1, 2003; 40(5): 380 - 384. [Full Text] [PDF]
|
|
|
|
|
|
H Leonard, L Colvin, J Christodoulou, T Schiavello, S Williamson, M Davis, D Ravine, S Fyfe, N de Klerk, T Matsuishi, et al. Patients with the R133C mutation: is their phenotype different from patients with Rett syndrome with other mutations? J. Med. Genet., May 1, 2003; 40(5): e52 - 52. [Full Text] [PDF]
|
|
|
|
|
|
G. M. Liebhaber, E. Riemann, and F. A. Matthias Baumeister Ketogenic Diet in Rett Syndrome J Child Neurol, January 1, 2003; 18(1): 74 - 75. [Abstract] [PDF]
|
|
|
|
 |
|
 L Colvin, S Fyfe, S Leonard, T Schiavello, C Ellaway, N de Klerk, J Christodoulou, M Msall, and H Leonard Describing the phenotype in Rett syndrome using a population database Arch. Dis. Child., January 1, 2003; 88(1): 38 - 43. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. M. Solaas, O. Skjeldal, M. L. G. Gardner, B. F. Kase, and K. L. Reichelt Urinary Peptides in Rett Syndrome Autism, September 1, 2002; 6(3): 315 - 329. [Abstract] [PDF]
|
|
|
|
|
|
F Laccone, B Zoll, P Huppke, F Hanefeld, W Pepinski, and R Trappe MECP2 gene nucleotide changes and their pathogenicity in males: proceed with caution J. Med. Genet., August 1, 2002; 39(8): 586 - 588. [Full Text] [PDF]
|
|
|
|
|
|
Jong Hee Chae, Yong Seung Hwang, and Ki Joong Kim Mutation Analysis of MECP2 and Clinical Characterization in Korean Patients With Rett Syndrome J Child Neurol, January 1, 2002; 17(1): 33 - 36. [Abstract] [PDF]
|
|
|
|
|
|
V. Bourdon, C. Philippe, T. Bienvenu, B. Koenig, M. Tardieu, J. Chelly, and P. Jonveaux Evidence of somatic mosaicism for a MECP2 mutation in females with Rett syndrome: diagnostic implications J. Med. Genet., December 1, 2001; 38(12): 867 - 871. [Full Text] [PDF]
|
|
|
|
|
|
J. M. LaSalle, J. Goldstine, D. Balmer, and C. M. Greco Quantitative localization of heterogeneous methyl-CpG-binding protein 2 (MeCP2) expression phenotypes in normal and Rett syndrome brain by laser scanning cytometry Hum. Mol. Genet., August 1, 2001; 10(17): 1729 - 1740. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. Hoffbuhr, J. M. Devaney, B. LaFleur, N. Sirianni, C. Scacheri, J. Giron, J. Schuette, J. Innis, M. Marino, M. Philippart, et al. MeCP2 mutations in children with and without the phenotype of Rett syndrome Neurology, June 12, 2001; 56(11): 1486 - 1495. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. Leonard, J. Silberstein, R. Falk, I. Houwink-Manville, C. Ellaway, L. S. Raffaele, I. Witt Engerstrom, and C. Schanen Occurrence of Rett Syndrome in Boys J Child Neurol, May 1, 2001; 16(5): 333 - 338. [Abstract] [PDF]
|
|
|
|
|
|
P. Couvert, T. Bienvenu, C. Aquaviva, K. Poirier, C. Moraine, C. Gendrot, A. Verloes, C. Andres, A. C. Le Fevre, I. Souville, et al. MECP2 is highly mutated in X-linked mental retardation Hum. Mol. Genet., April 1, 2001; 10(9): 941 - 946. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. Webb and F. Latif Rett syndrome and the MECP2 gene J. Med. Genet., April 1, 2001; 38(4): 217 - 223. [Full Text]
|
|
|
|
|
|
H. S. Singer and S. Naidu Rett syndrome "We'll keep the genes on for you" Neurology, March 13, 2001; 56(5): 582 - 584. [Full Text] [PDF]
|
|
|
|
|
|
M. Auranen, R. Vanhala, M. Vosman, M. Levander, T. Varilo, M. Hietala, R. Riikonen, L. Peltonen, and I. Jarvela MECP2 gene analysis in classical Rett syndrome and in patients with Rett-like features Neurology, March 13, 2001; 56(5): 611 - 617. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T. M. Yusufzai and A. P. Wolffe Functional consequences of Rett syndrome mutations on human MeCP2 Nucleic Acids Res., November 1, 2000; 28(21): 4172 - 4179. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. Villard, A. Kpebe, C. Cardoso, J. Chelly, M. Tardieu, and M. Fontes Two affected boys in a Rett syndrome family: Clinical and molecular findings Neurology, October 24, 2000; 55(8): 1188 - 1193. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. Dragich, I. Houwink-Manville, and C. Schanen Rett syndrome: a surprising result of mutation in MECP2 Hum. Mol. Genet., October 1, 2000; 9(16): 2365 - 2375. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Free, R. I. D. Wakefield, B. O. Smith, D. T. F. Dryden, P. N. Barlow, and A. P. Bird DNA Recognition by the Methyl-CpG Binding Domain of MeCP2 J. Biol. Chem., January 26, 2001; 276(5): 3353 - 3360. [Abstract] [Full Text] [PDF]
|
|